Meet Cromos Pharma’s CEO at the 38th Annual J.P Morgan Healthcare Conference

09 December 2019

Cromos Pharma’s CEO and founder, Vlad Bogin, MD, FACP, will attend the 38th Annual J.P Morgan Healthcare Conference, 13-16 January 2020 in San Francisco, California.

The J.P. Morgan Healthcare Conference brings together healthcare industry leaders, innovative technology companies and investors from over 450 public and private companies and attracts over 9000 attendees. It is a unique opportunity to network with leaders from these inter-related sectors while catching up on the latest developments in the healthcare industry.

If you are in San Francisco on these dates, Dr Bogin would be delighted to meet with you to discuss how Cromos Pharma can support your clinical trials from strategic early phase study design to the final report. Please contact us to arrange a meeting or an informal chat over a coffee.

Cromos Pharma is celebrating 15 years of clinical research excellence. It is a growing, dynamic international CRO with expertise in delivering all aspects of clinical trials in all clinical phases and a range of therapeutic areas. Cromos Pharma offers fully integrated CRO services including regulatory consulting and compliance, project management, monitoring, medical writing, post-marketing services and independent audits. Cromos Pharma delivers rapid recruitment and excellent patient retention as well as expert study design and management. Cromos Pharma has strong regional experience in Central and Eastern Europe, Russia and Post-Soviet Bloc countries. Its European HQ is situated in Dublin, Ireland and its US base is in Portland, Oregon. Find out more by visiting www.cromospharma.com


Back to the news